Cargando…
Benefits of dexamethasone on early outcomes in patients with acute myeloid leukemia with hyperleukocytosis: a propensity score matched analysis
Hyperleukocytosis is associated with a significant early mortality rate in patients with acute myeloid leukemia (AML). To date, no controlled trial has ever evaluated a strategy to reduce this risk, and the initial management of these patients remains heterogeneous worldwide. The aim of the present...
Autores principales: | Cerrano, Marco, Chevret, Sylvie, Raffoux, Emmanuel, Rabian, Florence, Sébert, Marie, Valade, Sandrine, Itzykson, Raphael, Lemiale, Virginie, Adès, Lionel, Boissel, Nicolas, Dombret, Hervé, Azoulay, Elie, Lengliné, Etienne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9919741/ https://www.ncbi.nlm.nih.gov/pubmed/36773040 http://dx.doi.org/10.1007/s00277-023-05119-3 |
Ejemplares similares
-
Post-remission outcomes in AML patients with high hyperleukocytosis and inaugural life-threatening complications
por: Fodil, Sofiane, et al.
Publicado: (2022) -
The use of ICU resources in CAR-T cell recipients: a hospital-wide study
por: Valade, Sandrine, et al.
Publicado: (2022) -
Acute Kidney Injury in Patients with Newly Diagnosed High-Grade Hematological Malignancies: Impact on Remission and Survival
por: Canet, Emmanuel, et al.
Publicado: (2013) -
Allogeneic transplantation in acute myelogenous leukemia: a comprehensive single institution's experience
por: Socie, Gerard, et al.
Publicado: (2023) -
Clinical Warburg effect in lymphoma patients admitted to intensive care unit
por: Chaba, Anis, et al.
Publicado: (2023)